---
$id: https://graph.org.ai/products/commodity/51241256
$type: Product
source: UNSPSC
code: "51241256"
title: "Becaplermin"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Becaplermin

**UNSPSC Code**: 51241256
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a platelet-derived growth factor with the molecular formula C532H892N162O153S9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1B56C968OA, more generally known as becaplermin. European Medicines Agency schedules becaplermin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00680MIG. The term BECAPLERMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, no. 3, 1996, list 36. BECAPLERMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Becaplermin under HS 29371900 and SITC 54154. SMILES:. As of Q4 2014, BECAPLERMIN remains the US FDA Preferred Term for this commodity. . Becaplermin bears US NLM identifiers UMLS ID C0379135 and NCI Concept Code C1668.

